Deep Analysis of Impact of COVID-19 on “Cardiac Prosthetic Devices Market 2019-2025” Growth Worldwide….



The global cardiac prosthetic device market size is expected to be over USD 8.7 billion by 2025, based on a new study by Grand View Research, Inc. Rising demand for minimally invasive devices has provided greater growth prospects for the market. New product development through technological advancements is anticipated to foster market growth. The major companies are focusing on expanding their product life and safety benefits of the cardiac prosthetic devices. Such initiatives undertaken by the key players have resulted in increasing survival rates and low stroke rates for transcatheter aortic valves.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
Transcatheter aortic valve replacement (TAVR) is covered by Evidence Development (CED) Coverage provided by the Centers for Medicare & Medicaid Services (CMS). Cardiac pacemakers are also covered under Medicare program. Initiatives for reimbursement from the government for such devices are anticipated to boost the demand for cardiac prosthetic devices.
Some key players include Medtronic, Inc.; Boston Scientific Corporation; St. Jude Medical, Inc.; Edwards Lifesciences Corporation; Siemens Healthcare GmbH; Abbott Vascular; and Sorin Group.

The companies are focusing on new product development, geographical expansion, and mergers & acquisitions. For instance, in 2016, St. Jude Medical announced the launch of Trifecta Valve with Glide Technology in the U.S. They are utilizing advanced technology, which is further expected to foster the growth of the industry.
To Request Sample Copy of this report, click the link:
Further Key Findings From the Study Suggest:
·         Heart valve segment was one of the largest segments in 2015 owing to rising prevalence of valvular disease and heart valve failure.
·         Pacemakers segment is expected to grow significantly, owing to rising reimbursement policies for pacemaker-related surgeries.
·         Mechanical heart valve segment contributed toward the one of the largest market share in 2015 owing to its increasing product longevity. Moreover, they provide better hemodynamic efficiency. Since mechanical valves are made up of strong durable materials, such as titanium and carbon, they are preferred over other cardiac prosthetic devices.
·         Transcatheter valve is expected to exhibit lucrative CAGR over the forecast period. TAVR has shown improved patient survival rate as compared to medical therapy. In the past years, it has evolved as a minimally invasive alternative treatment for surgical valve replacement.
·         Implantable pacemakers are one of the highest revenue generating segments owing to their greater applicability pertaining to heart failure (HF) and other cardiovascular diseases like stroke.
·         North America contributed toward the largest market share of around 40.0% in 2015. This is primarily due to the fact that the number of pacemaker implantations has increased amongst the Americans over the past two decades. Moreover, companies are focusing on commercial availability of technologically advanced devices in the U.S.
·         Asia Pacific is anticipated to witness highest CAGR over the forecast period owing to the growing geriatric population in Japan. In 2015, the geriatric population base accounted for around 27% in Japan.
·         Some key companies in cardiac prosthetic devices market are Medtronic, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Abbott Vascular; Siemens Healthcare GmbH; and Sorin Group.
·         New product development through introduction of advanced technology and mergers & acquisitions are some of the key strategies adopted by the companies to enhance the demand for cardiac prosthetic devices. For instance, in 2015, St. Jude Medical and Thoratec, a company that specializes in mechanical circulatory support technology for the treatment of advanced HF, entered into a definitive agreement aiming at acquisition of the outstanding shares of Thoratec.
The global cardiac prosthetic devices market size was valued at USD 3.7 billion in 2015 and is expected to witness attractive growth over the forecast period. The major companies are enhancing the longevity of their product through technological advancements. These companies are also focusing on expanding the safety of the cardiac prosthetic devices, which is expected to increase the demand for such products.
Around 610,000 people are reported to die every year in the U.S. owing to cardiovascular diseases. Disorders like stroke and prosthetic valve failure lead to high mortality rates, which will impact the market to a great extent, thereby, boosting the demand for valve replacement devices and pacemakers. Stroke is one of the most frequently occurring cardiovascular disorders amongst the geriatric population, which leads to acute prosthetic heart failure. Dyspnea also leads to such heart failure, which is expected to increase the need for products related to cardiac prosthetics.
Geriatric population plays a pivotal role in the increasing demand for cardiac prosthetic devices. They have a higher susceptibility to develop degenerative cardiac diseases, which is expected to positively impact the market to a great extent. Hence, with rising geriatric population base, the risk of cardiovascular diseases is estimated to rise. Asia Pacific experienced the maximum deaths in 2013 from such diseases. The geriatric population base is also more likely to experience longer hospitalization related to cardiovascular disorders.
Have any Query? Ask our Experts:
Grand View Research has segmented the global cardiac prosthetic device market on the basis of product:
Cardiac Prosthetic Device Product Outlook (Market Revenue in USD Million, 2014 - 2025)
·         Heart valves
o    Mechanical valve
o    Tissue valve
o  Stented tissue valve
o  Stentless tissue valve
o    Transcatheter valve
·         Pacemakers
o    Implantable pacemakers
o  Single-Chamber Battery Pacemaker
o  Dual-Chamber Battery Pacemaker
o  Triple-Chamber Battery Pacemaker
o    External pacemakers
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.




Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..